Literature DB >> 6609631

Delayed diagnosis in congenital adrenal hyperplasia. Need for newborn screening.

R M Lebovitz, R M Pauli, R Laxova.   

Abstract

Medical records of all patients with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency who were followed up at the University of Wisconsin Hospitals, Madison, from 1956 to 1979, were reviewed to document the ages at diagnoses. Without newborn screening, the average age at diagnosis for 32 patients was 12.6 months (7.3 months for female infants and children and 22.7 months for male infants and children). In the newborn population, ambiguity was recognized in 15 of 21 female infants and in none of the male infants. Initial-appearing symptoms in female infants and children included ambiguous genitalia in 15 of 21, precocious puberty in four, and salt-losing crises in two. In the male infants and children, the reasons for diagnoses were salt-losing crises in seven of 11 and precocious puberty in four. These results indicate that in the absence of newborn screening, diagnosis is frequently delayed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6609631     DOI: 10.1001/archpedi.1984.02140440055014

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  11 in total

Review 1.  Novel basic and clinical aspects of congenital adrenal hyperplasia.

Authors:  D P Merke; C A Camacho
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment.

Authors:  D Merke; M Kabbani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

4.  Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.

Authors:  I A Hughes
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

5.  Congenital adrenal hyperplasia in Birmingham: a retrospective analysis (1958-1985).

Authors:  N K Virdi; A Green
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

6.  Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline.

Authors:  Phyllis W Speiser; Ricardo Azziz; Laurence S Baskin; Lucia Ghizzoni; Terry W Hensle; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; Victor M Montori; Sharon E Oberfield; Martin Ritzen; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2010-09       Impact factor: 5.958

7.  Should we screen for congenital adrenal hyperplasia? A review of 117 cases.

Authors:  N K Virdi; P H Rayner; B T Rudd; A Green
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

8.  Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline.

Authors:  Phyllis W Speiser; Wiebke Arlt; Richard J Auchus; Laurence S Baskin; Gerard S Conway; Deborah P Merke; Heino F L Meyer-Bahlburg; Walter L Miller; M Hassan Murad; Sharon E Oberfield; Perrin C White
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

9.  Long-term Follow up of Congenital Adrenal Hyperplasia Patients with Hyponatremia.

Authors:  Jun Hyuk Song; Kyu Ha Lee; Sung Do Kim; Byoung Soo Cho
Journal:  Electrolyte Blood Press       Date:  2007-12-31

10.  Male Gender Identity and Reversible Hypokalemic Hypertension in a 46,XX Child with 11-Beta-Hydroxylase Deficiency Congenital Adrenal Hyperplasia.

Authors:  Alpesh Goyal; Hiya Boro; Rajesh Khadgawat
Journal:  Cureus       Date:  2019-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.